z-logo
open-access-imgOpen Access
Media, informacja a szczepienia przeciw COVID-19
Author(s) -
Katarzyna Bałandynowicz-Panfil,
AUTHOR_ID
Publication year - 2021
Publication title -
media, biznes, kultura
Language(s) - English
Resource type - Journals
eISSN - 2544-2554
pISSN - 2451-1986
DOI - 10.4467/25442554.mbk.21.023.15164
Subject(s) - european union , government (linguistics) , psychological resilience , pandemic , political science , social media , population , politics , public relations , resilience (materials science) , empirical research , covid-19 , sociology , social psychology , psychology , business , medicine , law , linguistics , philosophy , physics , demography , disease , epistemology , pathology , infectious disease (medical specialty) , economic policy , thermodynamics
The fourth wave of the COVID-19 pandemic is another significant confession for European societies. Despite extensive efforts, a safe level of population resilience has not been achieved in most countries. Previous actions and government programs aimed at persuading as many people as possible to accept vaccinations. Full availability of free vaccination has brought different levels of participation in fully vaccinated people across the European Union. This article presents the preliminary results of research on the role of the media in shaping pro-vaccination attitudes in Poland, based on a critical analysis of the literature on the subject, statistical data and an empirical research. The differences in attitudes towards vaccination against the SARS-CoV-2 virus in individual European Union countries have multifaceted conditions. These include factors of a social, political and cultural nature. Information plays an important role, shaping social attitudes in the discussed issue. One of the primary sources of this information is media – both traditional and digital. It is therefore worth defining the strength of media in the fight to build population resilience in the face of a pandemic.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here